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CSF inflammatory markers differ in grampositive versus gram-negative shunt
infections
Gwenn L. Skar1* , David Synhorst2, Matthew Beaver1 and Jessica N. Snowden3

Abstract
Background: Cerebrospinal fluid (CSF) shunt placement is frequently complicated by bacterial infection. Shunt
infection diagnosis relies on bacterial culture of CSF which can often produce false-negative results. Negative cultures
present a conundrum for physicians as they are left to rely on other CSF indices, which can be unremarkable. New
methods are needed to swiftly and accurately diagnose shunt infections. CSF chemokines and cytokines may prove
useful as diagnostic biomarkers. The objective of this study was to evaluate the potential of systemic and CSF
biomarkers for identification of CSF shunt infection.
Methods: We conducted a retrospective chart review of children with culture-confirmed CSF shunt infection at Children’s
Hospital and Medical Center from July 2013 to December 2015. CSF cytokine analysis was performed for those patients
with CSF in frozen storage from the same sample that was used for diagnostic culture.
Results: A total of 12 infections were included in this study. Patients with shunt infection had a median C-reactive protein
(CRP) of 18.25 mg/dL. Median peripheral white blood cell count was 15.53 × 103 cells/mL. Those with shunt infection had
a median CSF WBC of 332 cells/mL, median CSF protein level of 406 mg/dL, and median CSF glucose of 35.5 mg/dL. An
interesting trend was observed with gram-positive infections having higher levels of the anti-inflammatory cytokine
interleukin (IL)-10 as well as IL-17A and vascular endothelial growth factor (VEGF) compared to gram-negative infections,
although these differences did not reach statistical significance. Conversely, gram-negative infections displayed higher
levels of the pro-inflammatory cytokines IL-1β, fractalkine (CX3CL1), chemokine ligand 2 (CCL2), and chemokine ligand 3
(CCL3), although again these were not significantly different. CSF from gram-positive and gram-negative shunt infections
had similar levels of interferon gamma (INF-γ), tumor necrosis factor alpha (TNF-α), IL-6, and IL-8.
Conclusions: This pilot study is the first to characterize the CSF cytokine profile in patients with CSF shunt infection and
supports the distinction of chemokine and cytokine profiles between gram-negative and gram-positive infections.
Additionally, it demonstrates the potential of CSF chemokines and cytokines as biomarkers for the diagnosis of shunt
infection.
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Background
Cerebrospinal fluid (CSF) shunts are the most common
treatment of hydrocephalus in the USA; however, they
are frequently complicated by bacterial infection [1].
Shunt infections are responsible for approximately 2400
admissions and 59,000 hospital days annually in the
USA [2]. Bacteria cause the majority of shunt infections,
with Staphylococcus epidermidis and Staphylococcus aureus among the leading causes [3–6]. Apart from
staphylococci, Propionibacterium acnes, enterococci, and
a variety of gram-negative bacteria including Pseudomonas aeruginosa and Escherichia coli commonly cause
shunt infections [3–7].
Shunt infections present unique diagnostic and treatment challenges, since they are biofilm rather than
planktonic infections [8]. Bacteria adhere to the catheter
and form a biofilm, communities of bacteria which are
tolerant to antibiotics and actively avoid immune clearance [9]. Thus, the inflammatory response to biofilm infection is distinct from planktonic infection, such as
bacterial meningitis or intracranial abscess [9–12]. Due
to their biofilm nature, shunt infection treatment requires both removal of the infected shunt and days or
weeks of intravenous antibiotics [13]. With the extensive
nature of treatment, it is essential that shunt infections
are diagnosed accurately and rapidly.
While newer DNA-based detection methods are being
instituted in the clinical microbiology laboratory, the
gold standard method to diagnose shunt infection currently relies on isolating a pathogen from CSF culture
[13–19]. While DNA sequencing methods for microbiological diagnosis are promising, they also have pitfalls,
particularly in the case of shunt infection where many
sequenced pathogens are common skin flora. The utility
of broad-range polymerase chain reaction (PCR) may be
limited by contamination with skin flora during collection and handling as well as antibiotic administration before a diagnosis is made [16]. The only multiplex PCR
panel that is currently commercially available for meningitis/encephalitis has a limited spectrum of bacterial organisms, which is too narrow to be diagnostically useful
for cerebrospinal fluid shunt infections, where Staphylococcus epidermidis and Staphylococcus aureus are the
predominant organisms that are not included in this
panel [3–6].
Traditional CSF culture normally requires 24–48 h to
isolate organisms, and some slower growing organisms
may require several days of incubation, which can delay
appropriate treatment [20]. Additionally, if the patient
has received antibiotics prior to the CSF culture, the culture may be falsely negative. In these cases, a clinician
must rely on CSF indices such as cell count and differential, glucose, protein levels, and Gram stain, as well as
clinical presentation, to determine if an infection is
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present [19]. A better modality to accelerate and accurately diagnose CSF shunt infections would improve our
ability to treat these infections.
Identifying biomarkers in the CSF or serum of patients
with shunt infection may improve our ability to diagnose
CSF shunt infections. Biomarkers are distinct biochemical, genetic, or molecular substances that characterize
infection [20, 21]. There are a few small studies that
have evaluated the ability of CSF chemokines and cytokines to characterize different bacterial and viral meningitis. Many studies have examined the utility of using
chemokines and cytokines for the diagnosis of meningitis. In early meningeal infection, the pro-inflammatory
cytokines interleukin (IL)-8, IL-1, tumor necrosis factor
alpha (TNF-α), and IL-6 have been shown to be elevated
[22–25]. These mediators are released from CNS resident cells and function to recruit neutrophils and perpetuate the inflammatory response [26, 27]. Once
monocytes are recruited, the anti-inflammatory cytokine
IL-10 and IL-1β dampen inflammation by inhibiting production of pro-inflammatory cytokines [28].
Several studies have examined the possibility of using
chemokines and cytokines as biomarkers for meningitis
in the pediatric population. Elevated IL-8, IL-1β, TNF-α,
and IL-6 have routinely been shown to be elevated in
bacterial meningitis [23–25, 29, 30]. Another study revealed that cytokines could be used to discriminate between meningitis caused by Streptococcus pneumoniae,
Neiserria meningitidis, and Haemophilus influenzae
based on levels of interferon gamma (IFN-γ), monocyte
chemoattractant protein-1 (MCP-1), and the enzyme
matrix metallopeptidase-9 (MMP-9) [31].
Studies by Srinivasan et al. [25] in neonates with meningitis have investigated the utility of cytokines as diagnostic markers in this population. They found that
TNF-α, IL-1, IL-6, IL-8, IL-10, and IL-12 levels were significantly elevated in infants with bacterial meningitis.
However, none of these cytokines were considered sufficiently accurate for a differential diagnosis, which led to
the examination of IL-23, IL-18, and soluble receptor for
advanced glycation end products (sRAGE) in the same
population [32]. The authors concluded that IL-23 might
be a valuable biomarker for the diagnosis of neonatal
bacterial meningitis and, when combined with IL-18 and
sRAGE, diagnosed meningitis with 100% sensitivity and
specificity [32]. Interestingly, relevant to the current report, of the 11 neonates with confirmed meningitis in
these studies, there were 4 patients with ventriculoperitoneal shunts in place [25, 32].
To date, no study has examined CSF chemokine and
cytokine expression exclusively in patients with CSF
shunt infections. Animal models of shunt infection suggest that the inflammatory response in these biofilm infections may be attenuated in comparison to planktonic
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infections; thus, by extension, the same cytokine and
chemokine responses may not be observed in shunt infections as in meningitis [9, 10, 33–35]. One study of
shunt infection identified a possible role for soluble
membrane attack complex in diagnosis of shunt infection, but this molecule was not able to identify many
cases of S. epidermidis infection, which is the most common cause of shunt infection [36]. Therefore, to
characterize potential biomarkers of CSF shunt infection,
we evaluated systemic indicators of infection as well as
CSF cytokines in a cohort of patients diagnosed with
CSF shunt infection.

Methods
In this retrospective study, we included all patients less
than or equal to 21 years of age with culture-confirmed
bacterial CSF shunt infection diagnosed between July 1,
2013, and December 31, 2015, at Children’s Hospital and
Medical Center (CHMC) in Omaha, Nebraska. Patients
were identified by International Classification of Disease,
9th revision coding, and confirmed by positive CSF culture results in accordance with the modified criteria for
nosocomial infection of the US Centers for Disease Control and Prevention [15]. CSF culture was performed in
the clinical microbiology laboratory at CHMC in accordance with the Clinical Microbiology Procedure Handbook [17]. CSF cell count, differential, glucose, and
protein levels were assessed in the clinical laboratory at
CHMC in accordance with Clinical & Laboratory Standards Institute protocols [37, 38].
Patients were excluded if their diagnostic CSF culture
was performed at another institution or grew yeast or if
no CSF culture data was available. All participants were
screened for additional inflammatory infection by medical chart review and were excluded if there was an additional inflammatory condition documented in the
medical record that would alter inflammatory markers,
such as a concomitant viral upper respiratory infection.
Data extracted from the patients’ chart included the
following: patient age, peripheral white blood cell
(WBC) count, peripheral C reactive-protein (CRP), CSF
WBC count and differential, CSF glucose, CSF protein,
and CSF culture results. Patient’s peripheral WBC, CRP,
CSF WBC and differential, CSF glucose, and CSF protein
were included if they were obtained within a 48-h window from the time of the CSF culture.
For those patients with CSF in frozen storage from the
same sample that was used for diagnostic culture, additional cytokine analysis was conducted. The CSF was
analyzed by multiplex analysis for cytokines and chemokines (Millipore Milliplex Billerica, MA). The multiplex
panels included the following: chemokine ligand 2
(CCL2), chemokine ligand 3 (CCL3), fractalkine
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(CX3CL1), vascular endothelial growth factor (VEGF),
TNF-α, IFN-γ, IL-1β, IL-6, IL-8, IL-10, and IL-17A.
Descriptive statistics were performed using SigmaPlot.
A t test was used to compare mean cytokine levels in
those patients with gram-positive shunt infection compared to those with gram-negative infection. This study
was approved by the University of Nebraska Medical
Center Institutional Review Board.

Results
A total of 11 individual patients with 12 separate shunt
infections were included in this study (Table 1). Patient
ages ranged from 5 weeks to 20 years with a median age
of 4 months. All patients had a culture-confirmed ventriculoperitoneal shunt infection. Organisms identified
from culture included the following: methicillin-resistant
Staphylococcus aureus (1), viridans group streptococci
(1), coagulase-negative staphylococci (2), Enterococcus
faecalis (1), Gemella haemolysans (1), Serratia marcescens (1), Pseudomonas aeruginosa (2), Escherichia coli
(1), Enterobacter cloacae (1), and Stenotrophomonas
maltophilia (1).
Of the eight patients with CRP, the median was 18.25
mg/dL (0.5–35.9 mg/dL). All but one patient had a peripheral WBC count performed within 48 h of their CSF
culture, and the median WBC was 15.53 × 103 cells/mL
(5.97–29.71 × 103 cells/mL). Nine patients had CSF
WBC within 48 h of their CSF culture with a median
CSF WBC of 332 cells/mL (24–1914 cells/mL). The
gram-positive infections appeared to have a neutrophil
predominance in the CSF while gram-negative infections
had a more varied cellular differential. Eight patients had
results for CSF protein and CSF glucose. CSF protein
had a median value of 406 mg/dL (24–600 mg/dL), and
CSF glucose had a median value of 35.5 mg/dL (20–75
mg/dL).
Seven of the patients had CSF available for cytokine
analysis; of these, three had gram-positive infections and
four had gram-negative. While not statistically significant, an interesting trend was observed with CSF from
patients with gram-positive infections having higher
levels of the anti-inflammatory cytokine IL-10 (1321.17
pg/mL vs 514.49 pg/mL) as well as IL-17A (193.95 pg/
mL vs 14.05 pg/mL) and VEGF (303.84 pg/mL vs 45.37
pg/mL) (Fig. 1). In contrast, the gram-negative group
had increases in IL-1β (1522.76 pg/mL vs 179.79 pg/mL)
and numerous chemokines, including CX3CL1 (532.93
pg/mL vs 187.95 pg/mL), CCL2 (7094.50 pg/mL vs
5741.00 pg/mL), and CCL3 (665.74 pg/mL vs 183.06 pg/
mL) (Fig. 1). Levels of IFN-γ (39.06 pg/mL vs 50.75 pg/
mL), TNF-α (184.14 pg/mL vs 215.41 pg/mL), IL-6
(5191.26 pg/mL vs 4816.35 pg/mL), and IL-8 (3390.38
pg/mL vs 2687.22 pg/mL) were similar in both
gram-negative and gram-positive infections (Fig. 1).
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Table 1 Patient age, CSF parameters, and CSF culture results
Patient Age
CRP Peripheral
number (months) (mg/ WBC
dL) (cells/mL)

CSF
CSF WBC
CSF protein
WBC differential
(mg/dL)
(cells/ (percentage)
mL)
N L M O

CSF glucose
(mg/dL)

CSF culture result

Cytokine analysis
performed

1

36

35.9

17.33

NA

NA

NA

NA

Methicillin-resistant
Staphylococcus aureus

No

2

5

NA

18.26

NA

NA

NA

NA

Viridans group streptococci

No

3

8

5.1

9.63

1575

98 0

1

0 166

20

Gemella haemolysans

No

4

3

17.4

8.54

985

99 1

0

0 600

21

Coagulase-negative
staphylococci

Yes

5

24

NA

NA

47

69 18 13 0 114

67

Coagulase-negative
staphylococci

Yes

6

240

8.9

29.71

377

86 6

0 600

75

Enterococcus faecalis

Yes

7

1.25

NA

12.2

NA

NA

NA

Enterobacter cloacae

No

7

3

NA

27.57

212

8

52 40 0 NA

NA

Serratia marcescens

No

8

3

0.5

13.33

332

26 31 43 0 212

23

Pseudomonas aeruginosa

Yes*

9

3

19.1

15.57

1914

80 1

20

Pseudomonas aeruginosa

Yes

10

84

27

12.73

24

8

61

Stenotrophomonas maltophilia Yes*

11

5

19.9

5.97

28

79 13 6

48

Escherichia coli

8

10 9 600

21 68 3 24
2 600

Yes

CRP C-reactive protein, WBC white blood cell count, CSF cerebrospinal fluid, N neutrophils, L lymphocytes, M monocytes, O other cell type, NA data not available
*Not included in analysis for IFN-γ of IL-17A

Discussion
Prompt diagnosis of shunt infection can allow for earlier
treatment, including surgical intervention, potentially
averting damaging consequences such as seizures and
reduced IQ [39, 40]. However, CSF cultures may be
negative due to prior antibiotic treatment or the difficulty of traditional culture in detecting biofilm infections. In these settings, clinicians are forced to use CSF
indices and peripheral markers of inflammation to diagnose shunt infection. As observed in our cohort, peripheral leukocytosis is not always present in shunt infection
and is very non-specific. CRP elevation was noted in our
cohort and in others, but this has been inconsistent in
other case studies [20, 21, 41]. CSF leukocytosis is a
more specific measure for CSF infection and was observed in this group of patients. However, this can also
occur in the setting of uninfected post-surgical inflammation, which presents a significant confounder as the
post-surgical period is also the highest risk for shunt infection [42]. CSF protein was elevated in our cohort; unfortunately, prior studies have shown that CSF protein
levels cannot distinguish aseptic post-surgical inflammation from shunt infection [42]. While hypoglycorrhachia
occurred in our patients, this is again unable to differentiate post-surgical chemical meningitis from shunt infection [42]. In this population where infection most
commonly occurs within 30 days of surgery, it is crucial
to be able to differentiate post-surgical inflammation
from shunt infection. Identification of more specific

markers of infection is essential to improve our ability to
identify these infections.
Pro-inflammatory mediators have been explored as a
diagnostic strategy for bacterial meningitis. Multiple
studies have demonstrated elevated levels of TNF-α,
IL-6, and IL-8 in the CSF of patients with bacterial meningitis, especially in the pediatric population [22–25, 29,
30]. While there is promising data for TNF-α, IL-6, and
IL-8 as diagnostic biomarkers in meningitis, CSF shunt
infections are a biofilm rather than planktonic infection
which skews the host immune response [10, 12]. Therefore, we examined cytokine/chemokine expression in the
CSF of patients with gram-positive and gram-negative
shunt infection.
The results of our study demonstrated similar levels of
INF-γ, TNF-α, IL-6, and IL-8 in the CSF of patients with
both gram-positive and gram-negative CSF shunt infections. This is consistent with results from Srinivasan et
al. [25], which demonstrated elevated levels of these mediators in neonates with meningitis, 36% percent of
which had a shunt infection. Our data as well as multiple studies in pediatric meningitis demonstrate that
TNF-α, IL-6, and IL-8 are present in the CSF of patients
with neurologic infection; however, these are likely not
good markers for differentiating shunt infection from
meningitis [24, 25, 30].
In our cohort, there were trends of a distinct inflammatory
response in gram-positive versus gram-negative shunt infections. CSF from patients with gram-positive infections had
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Fig. 1 CSF from patients with gram-positive infection has elevated levels of IL-10 (a), IL-17A (b), and VEGF (c) compared to gram-negative
infections. Gram-negative shunt infections demonstrate increases in IL-1β (d), Cx3CL1 (E), CCL2 (f), and CCL3 (g). Gram-positive and gram-negative
infections resulted in nearly equivalent levels of INF-γ (h), TNF-α (i), IL-6 (j), and IL-8 (k). n = 3 patients in gram-positive group, n = 2–4 gramnegative group (2 samples had sufficient quantity for measurement of IFN-γ and IL-17A)

higher levels of the anti-inflammatory cytokine IL-10 as well
as IL-17A and VEGF. Those with gram-negative infection
had higher levels of the pro-inflammatory cytokines IL-1β,
CX3CL1 CCL2, and CCL3.

The increase in IL-10 in the gram-positive patients is
consistent with a murine model of S. epidermidis CNS
catheter infection [34]. This study demonstrated elevated
levels of IL-10 in mice with S. epidermidis infected
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compared to sterile catheters [34]. IL-10 is an
anti-inflammatory cytokine essential for controlling the
production of pro-inflammatory cytokines [43, 44]. It is
known to play a role in acute and chronic inflammation
in the CNS, and in the setting of CNS catheter infection,
its presence may curb the inflammatory environment
[34, 45]. Additionally, the presence of IL-10 has been
highly associated with other types of staphylococcal infection. Rose et al. [46] demonstrated patients with elevated levels of IL-10 at the time of presentation with
Staphylococcus aureus blood stream infection had higher
mortality. Interestingly, two of the patients included in
our cytokine analysis cohort had coagulase-negative
staphylococcal infections. The increase in IL-10 may be
dampening pro-inflammatory mediators, such as the elevated IL-17A and VEGF seen in these patients, and serving a neuroprotective role. This is being further
evaluated in animal models of shunt infection.
In addition to increased IL-10, patients with
gram-positive infections had higher levels of IL-17A and a
neutrophil predominance in the CSF when compared to
patients with gram-negative shunt infection. This is consistent with IL-17’s role as an inducer of neutrophil chemokines, including IL-8, and IL-17’s importance in a
murine model of Staphylococcus aureus brain abscess [47,
48]. While shunt infections are biofilm rather than planktonic infections like brain abscess, the increased levels of
IL-17A and neutrophil predominance in the CSF in our
cohort suggest a Th17 response to gram-positive shunt infections in humans may predominate.
In addition to elevated IL-10 and IL-17A, patients with
gram-positive shunt infection had elevated levels of VEGF, a
potent mediator of vascular permeability associated with
cerebral edema and neutrophil migration in the CNS [49–
51]. VEGF has been shown to be elevated in a rabbit model
of Streptococcus pneumoniae meningitis as well as in tuberculous meningitis and other types of bacterial meningitis
[52–54]. VEGF may be playing a role in the disruption of the
blood-brain barrier in CNS infections, although it is unclear
why VEGF is higher in patients with gram-positive shunt infection. This will be explored further in future studies.
Our ability to evaluate whether the gram-negative
shunt infections have a Th1, Th2, or Th17 bias was limited due to sample availability. However, the data would
suggest a potential skewing towards a Th1 immune response in gram-negative shunt infection with increased
monocytes in the CSF of these patients compared to
gram-positive infection as well as increase in IL-1β and
a modest increase in INF-γ in gram-negative infection.
While there is limited data on the type of immune response gram-negative bacteria create in the CNS, studies
have demonstrated that gram-negative elicit Th1 immune responses in models of intestinal inflammatory
disorders [55, 56].
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The CSF patterns reported in this study are likely reflective of differing immune pathways triggered by
gram-positive versus gram-negative organisms [23]. Importantly, while chemokine and cytokine profiles have
been evaluated as CSF biomarkers of meningitis, evaluation of these markers in the setting of shunt infection
has been limited [25, 29, 31, 36]. Our results suggest that
the distinct cytokine profiles elicited by gram-positive
and gram-negative pathogens show promise as diagnostic tools for CNS shunt infections.

Conclusions
This pilot study is the first to characterize the CSF cytokine profile in patients with CSF shunt infection and has
revealed distinct chemokine and cytokine profiles between
gram-negative and gram-positive infections. While there
is an interesting trend in the CSF cytokines that could
greatly improve diagnosis of CSF shunt infection, there
are several limitations with this pilot study. Epidemiologically, coagulase-negative staphylococci is the most common cause of CSF shunt infection, causing approximately
two thirds of shunt infections, with Staphylococcus aureus
as the second most common cause [4, 5, 33]. In contrast,
this cohort of patients included a broad range of causative
bacteria which did not follow typical epidemiologic patterns. However, our data demonstrate the elevation of
chemokines and cytokines in the CSF of patients with
shunt infection demonstrating the potential of CSF chemokine and cytokine measurement serving as a diagnostic
strategy for shunt infection.
Secondly, in this small cohort, which was not large
enough to determine statistical significance, clear trends of
chemokines and cytokines were evident in gram-positive
versus gram-negative shunt infection. These trends demonstrate a potential Th17-predominant immune response to
gram-positive shunt infection and Th1-predominant response in gram-negative shunt infection. Additionally, due
to the restrictions of available CSF, there is not a control
population as CSF is not obtained from the shunts of well
children as there is the possibility of iatrogenic infection.
To address these limitations, we are currently developing a
rat model of CSF shunt infection to further delineate CSF
and serum inflammatory profiles in a controlled manner
that will allow for analysis of postoperative versus infective
changes. However, these pilot findings serve as a valuable
introduction to the potential of CSF chemokines and cytokines as biomarkers for the diagnosis of shunt infection. By
improving our ability to diagnose these infections, we can
provide earlier effective therapy in a disease process which
remains difficult to diagnose and treat.
Abbreviations
CCL2: Chemokine ligand 2; CCL3: Chemokine ligand 3; CNS: Central nervous
system; CRP: C-reactive protein; CSF: Cerebrospinal fluid; CX3CL1: Fractalkine;
IL: Interleukin; INF-γ: Interferon gamma; MCP-1: Monocyte chemoattractant

Skar et al. Journal of Neuroinflammation

Page 7 of 8

(2019) 16:7

protein-1; MMP-9: Matrix metallopeptidase-9; PCR: Polymerase chain reaction;
sRAGE: Soluble receptor for advanced glycation end products; TNF-α: Tumor
necrosis factor alpha; VEGF: Vascular endothelial growth factor; WBC: White
blood cell
Acknowledgements
The authors thank the clinical microbiology laboratory at Children’s Hospital
and Medical Center for providing banked patient samples. We would also
like to thank Tammy Kelian, PhD, for her assistance in the review and
revision of this manuscript.
Funding
This work was funded by the Pediatric Research Fund at the University of
Nebraska Medical Center.

8.

9.
10.
11.

12.

Availability of data and materials
The datasets used and/or analyzed during the current study are available
from the corresponding author on reasonable request.

13.

Authors’ contributions
GS designed the experiments; collected, analyzed, and interpreted the
patient data; and was a major contributor in writing the manuscript. DS
collected, analyzed, and interpreted the patient data. MB analyzed and
interpreted the patient data. JS designed the experiments, analyzed and
interpreted the patient data, and was a major contributor in writing the
manuscript. All authors read and approved the final manuscript.

14.

Ethics approval and consent to participate
This work was approved by the University of Nebraska Medical Center
Institutional Review Board (502-15-EP, 020-15-EP).
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.

Publisher’s Note

15.
16.

17.
18.

19.

Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.

20.

Author details
1
Department of Pediatrics, University of Nebraska Medical Center, 982162
Nebraska Medical Center, Omaha, NE 68198-2162, USA. 2Department of
Pediatrics, Children’s Mercy Hospital, Kansas City, MO, USA. 3Department of
Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

21.

Received: 31 August 2018 Accepted: 2 January 2019

References
1. Bondurant CP, Jimenez DF. Epidemiology of cerebrospinal fluid shunting.
Pediatr Neurosurg. 1995;23:254–8 discussion 259.
2. Simon TD, Butler J, Whitlock KB, Browd SR, Holubkov R, Kestle JR, Kulkarni
AV, Langley M, Limbrick DD Jr, Mayer-Hamblett N, Tamber M, Wellons JC
3rd, Whitehead WE, Riva-Cambrin J, Hydrocephalus Clinical Research
Network. Risk factors for first cerebrospinal fluid shunt infection: findings
from a multi-center prospective cohort study. J Pediatr. 2014;164:1462–8 e2.
3. Lee JK, Seok JY, Lee JH, Choi EH, Phi JH, Kim SK, Wang KC, Lee HJ. Incidence
and risk factors of ventriculoperitoneal shunt infections in children: a study
of 333 consecutive shunts in 6 years. J Korean Med Sci. 2012;27:1563.
4. Wells DL, Allen JM. Ventriculoperitoneal shunt infections in adult patients.
AACN Adv Crit Care. 2013;24:6–12 quiz 13-4.
5. Odio C, McCracken GH Jr, Nelson JD. CSF shunt infections in pediatrics. A
seven-year experience. Am J Dis Child. 1984;138:1103–8.
6. Prusseit J, Simon M, dB v, Heep A, Molitor E, Volz S, Simon A. Epidemiology,
prevention and management of ventriculoperitoneal shunt infections in
children. Pediatr Neurosurg. 2009;45:325–36.
7. Simon TD, Van Yserloo B, Nelson K, Gillespie D, Jensen R, McAllister JP 2nd,
Riva-Cambrin J, Stockmann C, Daly JA, Blaschke AJ. Use of quantitative 16S
rRNA PCR to determine bacterial load does not augment conventional

22.

23.

24.

25.

26.
27.

28.

29.

30.

cerebrospinal fluid (CSF) cultures among children undergoing treatment for
CSF shunt infection. Diagn Microbiol Infect Dis. 2014;78:188–95.
Fux CA, Quigley M, Worel AM, Post C, Zimmerli S, Ehrlich G, Veeh RH.
Biofilm-related infections of cerebrospinal fluid shunts. Clin Microbiol Infect.
2006;12:331–7.
Fey PD, Olson ME. Current concepts in biofilm formation of Staphylococcus
epidermidis. Future Microbiol. 2010;5:917–33.
Gries CM, Kielian T. Staphylococcal biofilms and immune polarization during
prosthetic joint infection. J Am Acad Orthop Surg. 2017;25(Suppl 1):S20–4.
Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The calgary biofilm
device: new technology for rapid determination of antibiotic susceptibilities
of bacterial biofilms. J Clin Microbiol. 1999;37:1771–6.
Heim CE, Vidlak D, Scherr TD, Kozel JA, Holzapfel M, Muirhead DE, Kielian T.
Myeloid-derived suppressor cells contribute to Staphylococcus aureus
orthopedic biofilm infection. J Immunol. 2014;192:3778–92.
Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van
de Beek D, Bleck TP, Garton HJ, Zunt JR. 2017 Infectious Diseases Society of
America’s clinical practice guidelines for healthcare-associated ventriculitis
and meningitis. Clin Infect Dis. 2017;64:34–65.
Deutch S, Dahlberg D, Hedegaard J, Schmidt MB, Moller JK, Ostergaard L.
Diagnosis of ventricular drainage-related bacterial meningitis by broadrange real-time polymerase chain reaction. Neurosurgery. 2007;61:306–11
discussion 311-2.
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for
nosocomial infections, 1988. Am J Infect Control. 1988;16:128–40.
Harris KA, Hartley JC. Development of broad-range 16S rDNA PCR for use in
the routine diagnostic clinical microbiology service. J Med Microbiol. 2003;
52:685–91.
Leber. Clinical microbiology procedures handbook. Washington, DC: ASM
Press; 2016.
Rampini SK, Bloemberg GV, Keller PM, Buchler AC, Dollenmaier G, Speck RF,
Bottger EC. Broad-range 16S rRNA gene polymerase chain reaction for
diagnosis of culture-negative bacterial infections. Clin Infect Dis. 2011;53:
1245–51.
Simon TD, Pope CE, Browd SR, Ojemann JG, Riva-Cambrin J, MayerHamblett N, Rosenfeld M, Zerr DM, Hoffman L. Evaluation of microbial
bacterial and fungal diversity in cerebrospinal fluid shunt infection. PLoS
One. 2014;9:e83229.
Lan CC, Wong TT, Chen SJ, Liang ML, Tang RB. Early diagnosis of
ventriculoperitoneal shunt infections and malfunctions in children with
hydrocephalus. J Microbiol Immunol Infect. 2003;36:47–50.
Lolak S, Bunyaratavej K. C-reactive protein in prediction of
ventriculoperitoneal shunt-related infection in high-risk patients. Surg Infect.
2013;14:192–5.
Mustafa MM. Role of tumor necrosis factor alpha (cachectin) in
experimental and clinical bacterial meningitis. Pediatr Infect Dis J. 1989;8:
907–8.
Perdomo-Celis F, Torres MA, Ostos H, Gutierrez-Achury J, Molano V, Duran
LF, Gonzalez G, Narvaez CF. Patterns of local and systemic cytokines in
bacterial meningitis and its relation with severity and long-term sequelae.
Biomark Insights. 2015;10:125–31.
Prasad R, Kapoor R, Srivastava R, Mishra OP, Singh TB. Cerebrospinal fluid
TNF-alpha, IL-6, and IL-8 in children with bacterial meningitis. Pediatr
Neurol. 2014;50:60–5.
Srinivasan L, Kilpatrick L, Shah SS, Abbasi S, Harris MC. Cerebrospinal fluid
cytokines in the diagnosis of bacterial meningitis in infants. Pediatr Res.
2016;80:566–72.
Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic
cytokines--CXC and CC chemokines. Adv Immunol. 1994;55:97–179.
Waage A. Local production of tumor necrosis factor alpha, interleukin 1, and
interleukin 6 in meningococcal meningitis. Relation to the inflammatory
response. J Exp Med. 1989;170:1859–67.
van Furth AM, Roord JJ, van Furth R. Roles of proinflammatory and antiinflammatory cytokines in pathophysiology of bacterial meningitis and
effect of adjunctive therapy. Infect Immun. 1996;64:4883–90.
Bociaga-Jasik M, Garlicki A, Ciesla A, Kalinowska-Nowak A, Sobczyk-Krupiarz I,
Mach T. The diagnostic value of cytokine and nitric oxide concentrations in
cerebrospinal fluid for the differential diagnosis of meningitis. Adv Med Sci.
2012;57:142–7.
Ye Q, Shao WX, Shang SQ, Shen HQ, Chen XJ, Tang YM, Yu YL, Mao JH.
Clinical value of assessing cytokine levels for the differential diagnosis of

Skar et al. Journal of Neuroinflammation

31.

32.
33.

34.

35.

36.

37.

38.

39.
40.

41.
42.
43.

44.
45.
46.

47.
48.
49.
50.

51.

52.

53.

(2019) 16:7

bacterial meningitis in a pediatric population. Medicine (Baltimore). 2016;95:
e3222.
Grandgirard D, Gaumann R, Coulibaly B, Dangy JP, Sie A, Junghanss T,
Schudel H, Pluschke G, Leib SL. The causative pathogen determines the
inflammatory profile in cerebrospinal fluid and outcome in patients with
bacterial meningitis. Mediat Inflamm. 2013;2013:312476.
Srinivasan L, Kilpatrick L, Shah SS, Abbasi S, Harris MC. Elevations of novel
cytokines in bacterial meningitis in infants. PLoS One. 2018;13:e0181449.
Gutierrez-Murgas Y, Snowden JN. Ventricular shunt infections:
immunopathogenesis and clinical management. J Neuroimmunol. 2014;276:
1–8.
Gutierrez-Murgas YM, Skar G, Ramirez D, Beaver M, Snowden JN. IL-10 plays
an important role in the control of inflammation but not in the bacterial
burden in S. epidermidis CNS catheter infection. J Neuroinflammation. 2016;
13:271.
Snowden JN, Beaver M, Beenken K, Smeltzer M, Horswill AR, Kielian T.
Staphylococcus aureus sarA regulates inflammation and colonization during
central nervous system biofilm formation. PLoS One. 2013;8:e84089.
Ramos TN, Arynchyna AA, Blackburn TE, Barnum SR, Johnston JM. Soluble
membrane attack complex is diagnostic for intraventricular shunt infection
in children. JCI Insight. 2016;1:e87919.
Franke D, Block DR, Algeciras-Schimnich A, et al. Analysis of body fluids in
clinical chemistry. 2nd ed. Wayne, Pennsylvania: Clinical and Laboratory
Standards Institute; 2018.
Szamosi DI, Bautista JM, Cornbleet J, et al. Body fluid analysis for cellular
composition; approved guideline. 1st ed. Wayne, Pennsylvania: Clinical and
Laboratory Standards Institute; 2006.
Piatt JH Jr. Cerebrospinal fluid shunt failure: late is different from early.
Pediatr Neurosurg. 1995;23:133–9.
Pirotte BJ, Lubansu A, Bruneau M, Loqa C, Van Cutsem N, Brotchi J. Sterile
surgical technique for shunt placement reduces the shunt infection rate in
children: preliminary analysis of a prospective protocol in 115 consecutive
procedures. Childs Nerv Syst. 2007;23:1251–61.
Yousif TI, O'Reilly K, Nadeem M. Blood tests are not always helpful in
predicting bacterial meningitis in children. Sudan J Paediatr. 2016;16:77–9.
Forgacs P, Geyer CA, Freidberg SR. Characterization of chemical meningitis
after neurological surgery. Clin Infect Dis. 2001;32:179–85.
Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and
functions of the IL-10 family of cytokines in inflammation and disease. Annu
Rev Immunol. 2011;29:71–109.
Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J. Biology
of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331–44.
Norden DM, Fenn AM, Dugan A, Godbout JP. TGFbeta produced by IL-10
redirected astrocytes attenuates microglial activation. Glia. 2014;62:881–95.
Rose WE, Shukla SK, Berti AD, Hayney MS, Henriquez KM, Ranzoni A, Cooper
MA, Proctor RA, Nizet V, Sakoulas G. Increased endovascular Staphylococcus
aureus inoculum is the link between elevated serum interleukin 10
concentrations and mortality in patients with bacteremia. Clin Infect Dis.
2017;64:1406–12.
Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of
T(H)17 cells. Nature. 2008;453:1051–7.
Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell
effector cytokines in inflammation. Immunity. 2008;28:454–67.
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat
Med. 2003;9:669–76.
Moromizato Y, Stechschulte S, Miyamoto K, Murata T, Tsujikawa A, Joussen
AM, Adamis AP. CD18 and ICAM-1-dependent corneal neovascularization
and inflammation after limbal injury. Am J Pathol. 2000;157:1277–81.
Proescholdt MA, Heiss JD, Walbridge S, Muhlhauser J, Capogrossi MC,
Oldfield EH, Merrill MJ. Vascular endothelial growth factor (VEGF) modulates
vascular permeability and inflammation in rat brain. J Neuropathol Exp
Neurol. 1999;58:613–27.
Matsuyama W, Hashiguchi T, Umehara F, Matsuura E, Kawabata M, Arimura
K, Maruyama I, Osame M. Expression of vascular endothelial growth factor
in tuberculous meningitis. J Neurol Sci. 2001;186:75–9.
van der Flier M, Stockhammer G, Vonk GJ, Nikkels PG, van DiemenSteenvoorde RA, van der Vlist GJ, Rupert SW, Schmutzhard E, Gunsilius E,
Gastl G, Hoepelman AI, Kimpen JL, Geelen SP. Vascular endothelial growth
factor in bacterial meningitis: detection in cerebrospinal fluid and
localization in postmortem brain. J Infect Dis. 2001;183:149–53.

Page 8 of 8

54. van der Flier M, Coenjaerts FE, Mwinzi PN, Rijkers E, Ruyken M, Scharringa J,
Kimpen JL, Hoepelman AI, Geelen SP. Antibody neutralization of vascular
endothelial growth factor (VEGF) fails to attenuate vascular permeability and
brain edema in experimental pneumococcal meningitis. J Neuroimmunol.
2005;160:170–7.
55. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, Jahn
HK, Dunay IR, Moter A, Gescher DM, Schumann RR, Gobel UB, Liesenfeld O.
Gram-negative bacteria aggravate murine small intestinal Th1-type
immunopathology following oral infection with toxoplasma gondii. J
Immunol. 2006;177:8785–95.
56. De Palma G, Cinova J, Stepankova R, Tuckova L, Sanz Y. Pivotal advance:
bifidobacteria and gram-negative bacteria differentially influence immune
responses in the proinflammatory milieu of celiac disease. J Leukoc Biol.
2010;87:765–78.

